Back to KROS
D. E. Shaw & Co., Inc. KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
15
Latest value
$254K
Q3 2026
Peak value
$21.1M
First seen
Q2 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2022 | $582K |
| Q1 2024 | $1.2M |
| Q2 2024 | $8M |
| Q3 2024 | $10.8M |
| Q4 2024 | $192K |
| Q1 2025 | $12.9M |
| Q2 2025 | $17.3M |
| Q3 2025 | $21.1M |
| Q4 2025 | $15.4M |
| Q1 2026 | $310K |
| Q1 2026 | $5.3M |
| Q2 2026 | $387K |
| Q2 2026 | $2.5M |
| Q3 2026 | $1.8M |
| Q3 2026 | $254K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $254K | 22.3K | — | — |
| Q3 2026 | $1.8M | 160.9K | — | — |
| Q2 2026 | $2.5M | 231.3K | — | — |
| Q2 2026 | $387K | 36.1K | — | — |
| Q1 2026 | $5.3M | 481.6K | — | — |
| Q1 2026 | $310K | 28.1K | — | — |
| Q4 2025 | $15.4M | 755.5K | — | — |
| Q3 2025 | $21.1M | 1.33M | — | — |
| Q2 2025 | $17.3M | 1.30M | — | — |
| Q1 2025 | $12.9M | 1.26M | — | — |
| Q4 2024 | $192K | 12.1K | — | — |
| Q3 2024 | $10.8M | 186.3K | — | — |
| Q2 2024 | $8M | 175.7K | — | — |
| Q1 2024 | $1.2M | 18.9K | — | — |
| Q2 2022 | $582K | 21.1K | — | — |